The trial of the third phase of Oxford’s corona vaccine is starting in India

After the United Kingdom, the trial of the third phase of the Oxford-AstraZeneca corona vaccine is also starting in India. On Monday, the issue was confirmed.

The University of Oxford said in a statement that 18,000 volunteers worldwide are currently receiving the vaccine. The British research team also said that every case is being monitored carefully.

  Learn about the COVID-19 pandemic from News Hour  

The human trial was temporarily suspended last week after a vaccinator fell ill in the UK.

In a separate statement, the British drugmaker AstraZeneca said the man already had encephalitis. Which, after taking the antidote, has had a negative effect. However, after the approval of the Medicines Health Regulatory Authority M-H-R-A, the trial started again in Britain.

Follow News Hour
News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments
Scroll Up
%d bloggers like this: